The Genome Science Institute held its inaugural Research Symposium, an interdisciplinary research symposium that explores genetic and genomic science, in the Boston University Medical Campus Hiebert Lounge on Thursday, Oct. 8. Sixty-three abstracts were submitted by students, post-doctoral fellows, and faculty from Institutions throughout the Boston area. Prizes were awarded in undergraduate, graduate and postdoctoral […]
A study by BU School of Public Health researchers, published ahead of print in the journal Environmental Health Perspectives, suggests that polyfluoroalkyl chemicals (PFCs) may affect serum cholesterol levels in people. The authors analyzed the relationship between serum concentrations of four PFCs-perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), perfluorooctane sulfonic acid (PFOS) and perfluorohexane sulfonic acid […]
Osamu Shimomura, PhD, BUSM Professor Emeritus and recipient of the 2008 Nobel Prize in Chemistry will address the BU Medical Campus community on November 17, 2009. He will speak on “Discovery of Green Fluorescent Protein, GFP: My Nobel Prize Lecture.”
Boston University Alumni Weekend ’09 was held Friday, October 23 to Sunday, October 25 and featured events for alumni from every school. This year, for the first time, combined events were held for all three schools on the Boston University Medical Campus (BUMC). The William J. Bicknell Lectureship in Public Health kicked things off on […]
A researcher at the BU School of Medicine became ill last weekend after being infected with the bacterium Neisseria meningitidis, which he had been studying in a BioSafety Level 2 laboratory. MED spokespeople say the researcher, whose identity has not been disclosed, does not have meningitis, but is infected with a bacterium that can cause the disease. Thomas Moore, Medical Campus associate provost for clinical research, says the researcher is responding well to antibiotics and is expected to make a full recovery.
Click here to see the BU Today story by Art Jahnke
Researchers from Boston University School of Medicine (BUSM) and Boston University School of Public Health (BUSPH) have shown that an employer-sponsored, internet-based diet and exercise program shows promise as a low-cost benefit to lower healthcare costs for those at higher risk for above-average costs and healthcare utilization such as cardiac, hyperlipidemia, hypertension or diabetes patients. […]
The Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine (BUSM) announced today that a recently deceased member of the NFL Hall of Fame suffered from the degenerative brain disease Chronic Traumatic Encephalopathy (CTE) when he died, becoming the 10th former NFL player diagnosed with the disease.
BUSM’s CityLab program has received a five year, $1.3 million grant from the National Institutes of Health (NIH) National Center for Research Resources (NCRR). With this award, BUSM’s CityLab program will expand its curriculum supplements with hands-on laboratory experiments and computer-generated simulations designed to impart an understanding and appreciation of the basic elements of clinical […]
Members of the Boston University Henry M. Goldman School of Dental Medicine (GSDM) community traveled to Honolulu, Hawaii to celebrate 150 years of the American Dental Association (ADA) at the 2009 Annual Session. The Session was held from October 1 to 4 and had approximately 24,644 registrants. “The Session was fantastic,” said attendee Clinical Associate […]
The Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine (BUSM) announced today that a deceased former college football player who died at age 42 was already suffering from the degenerative brain disease, Chronic Traumatic Encephalopathy (CTE). This is the first time an advanced case of CTE has been discovered in a college football player that did not play professionally.